Complications of second and third trimester pregnancies

Emergency Medicine Clinics of North America

Volumn 21, Issue 3, 2003, Pages 695-710

  Abbrescia, Kelly ^a,b   Sheridan, Barry ^a  

^a BROOKE ARMY MEDICAL CENTER   (United States)

^b Department of Emergency Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BETAMETHASONE; CALCIUM CHANNEL BLOCKING AGENT; CLINDAMYCIN; CORTICOSTEROID; DEXAMETHASONE; DIAZEPAM; ERYTHROMYCIN; HYDRALAZINE; INDOMETACIN; MAGNESIUM SULFATE; NICARDIPINE; NIFEDIPINE; PENICILLIN G; PHENYTOIN; UTERUS SPASMOLYTIC AGENT; VANCOMYCIN;

ANTIBIOTIC PROPHYLAXIS; CHORIOAMNIONITIS; DIABETIC KETOACIDOSIS; DRUG HYPERSENSITIVITY; ENDOMETRITIS; FEMALE; FETUS GROWTH; FETUS MATURITY; GASTROINTESTINAL HEMORRHAGE; HEART ARREST; HEART ARRHYTHMIA; HEART FAILURE; HEART MUSCLE ISCHEMIA; HEPATITIS; HUMAN; HYPOTENSION; KIDNEY FAILURE; LUNG EDEMA; MATERNAL HYPERTENSION; NEUROTOXICITY; NEWBORN SEPSIS; PLACENTA PREVIA; PREGNANCY COMPLICATION; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PRIORITY JOURNAL; RESPIRATION DEPRESSION; REVIEW; SECOND TRIMESTER PREGNANCY; SIDE EFFECT; SOLUTIO PLACENTAE; TACHYCARDIA; TETANY; THIRD TRIMESTER PREGNANCY;

EID: 0041857866     PISSN: 07338627     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8627(03)00043-9     Document Type: Article

References (56)

1. Gonik B, Creasy K. Preterm labor: its diagnosis and management. Am J Obstet Gynecol 1986;154:3.
2. Rosen P. Preterm labor. In: Rosen P, editor. Emergency medicine: concepts and clinical practice. St. Louis (MO): Mosby; 1998. p. 2374-5.
3. Travis BE, McCullough M. Pharmacotherapy of preterm labor. Pharmacother 1993;13:29.
4. Gyetvai K. Tocolytics for preterm labor: a systematic review. Obstet Gynecol 1999;94(5 Pt 2):869-77.
5. Elliott JP. Magnesium sulfate as a tocolytic agent. Am J Obstet Gynecol 1983;147:277.
6. Larmon JE, Ross BS, May WL, et al. Oral nicardipine versus intravenous magnesium sulfate for the treatment of preterm labor. Am J Obstet Gynecol 1999;181:1432-7.
7. Goodwin TM, Paul R, Silver H, et al. The effect of the oxytocin antagonist atosiban on preterm uterine activity in the human. Am J Obstet Gynecol 1994;170:474-8.
8. Goodwin TM, Valenzuela G, Silver H, et al. Treatment of preterm labor with the oxytocin antagonist atosiban. Am J Perinatol 1996;13:143-6.
9. National Institute of Health. National Institutes of Health consensus development conference statement: effect of corticosteroids for fetal maturation on perinatal outcomes. Am J Obstet Gynecol 1995;173:246-52.
10. American College of Obstetricians and Gynecologists. Premature rupture of membranes. ACOG technical bulletin 115. Washington (DC): American College of Obstetricians and Gynecologists; 1998.
11. Miller JM, Keane MWD, Horger EO. Premature rupture of membranes. Obstet Gynecol Clin North Am 1992;19:241.
12. Parry S, Strauss J. Mechanisms of disease: premature rupture of the fetal membranes. N Engl J Med 1998;338(10):663-70.
13. Smith R. A technic for the detection of rupture of the membranes: a review and preliminary report. Obstet Gynecol 1976;48:172.
14. Romero R, Mazor M. Infection and preterm labor. Clin Obstet Gynecol 1988;31:553.
15. Nelson DM, Stempel LE, Zuspan FP, et al. Association of prolonged preterm premature rupture of the membranes and abruptio placentae. J Reprod Med 1996;31:249.
16. Vintzileos AM, Campbell WA, Nochimson DJ, et al. Preterm premature rupture of the membranes: a risk factor for the development of abruptio placentae. Am J Obstet Gynecol 1987;156:1235.
17. Capeless EL, Mead PB. Management of preterm premature rupture of membranes: lack of a national consensus. Am J Obstet Gynecol 1987;157:11.
18. Vermillion ST, Soper DE, Chasedunn-Roark J. Neonatal sepsis after betamethasone administration to patients with preterm premature rupture of membranes. Am J Obstet Gynecol 1999;181(2):320-7.
19. Allen SR. Tocolytic therapy in preterm PROM. Clin Obstet Gynecol 1998;41(4):842-8.
20. Locksmith GJ. Antibiotic therapy in preterm premature rupture of membranes. Clin Obstet Gynecol 1998;41(4):864-9.
21. Edwards RK, Locksmith GJ, Duff P. Expanded-spectrum antibiotics with preterm premature rupture of membranes. Obstet Gynecol 2000;96(1):60-4.
22. Mercer BM, Miodovnik M, Thurnau GR, et al. Antibiotic therapy for reduction of infant morbidity after preterm premature rupture of membranes: a randomized trial. JAMA 1997;278:989-95.
23. Elimian A. Histologic chorioamnionitis, antenatal steroids, and perinatal outcomes. Obstet Gynecol 2000;96(3):333-6.
24. Wu YW. Chorioamnionitis as a risk factor for cerebral palsy: a meta-analysis. JAMA 2000;284(11):1417-24.
25. Mark SP. Chorioamnionitis and uterine function. Obstet Gynecol 2000;95(Pt 1):909-12.
26. Paterson M. The aetiology and outcome of abruptio placentae. Acta Obstet Gynecol Scand 1979;58:31.
27. Spinillo A, Fazzi E, Stronati E, et al. Severity of abruptio placenta and neuro-developmental outcome in low birth weight infants. Early Hum Dev 1993;35:44.
28. Darby MJ, Caritis SN, Shen-Schwarz S. Placental abruption in the preterm gestation: an association with chorioamnionitis. Obstet Gynecol 1989;74:88.
29. Hibbard B, Jeffcoate T. Abruptio placentae. Obstet Gynecol 1966;27:155.
30. Townsend RR, Laing FC, Jeffrey RB. Placental abruption associated with cocaine abuse. AJR Am J Roentgenol 1988;150:1339.
31. Pritchard J. The genesis of severe placental abruption. Am J Obstet Gynecol 1970;208:22.
32. Gabbe. Preterm labor. In: Gabbe SG, editor. Obstetrics-normal and problem pregnancies. New York: Churchill Livingstone; 1996. p. 509, 511, 512.
33. Towers C, Pircon R, Heppard M. Is tocolysis safe in the management of third-trimester bleeding? Am J Obstet Gynecol 1999;180(6):1572-8.
34. Rosati P. Clinical significance of placenta previa detected at early routine transvaginal scan. J Ultrasound Med 2000;19(8):581-5.
35. lyasu S, Saftlas A, Rowley D, et al. The epidemiology of placenta previa in the United States, 1979 though 1987. Am J Obstet Gynecol 1993;168:1424-9.
36. Hendricks MS. Previous cesarean section and abortion as risk factors for developing placenta previa. J Obstet Gynaecol Res 1999;25(2):137-42.
37. Bekku S. High incidence of respiratory distress syndrome (RDS) is infants born to mothers with placenta previa. J Matern Fetal Med 2000;9(2):110-3.
38. Crane JM. Maternal complications with placenta previa. Am J Perinatol 2000;17(2):101-5.
39. Wentworth P. Circumvallate and circummarginate placentas. Am J Obstet Gynecol 1968;102:44-7.
40. Lee W. Vasa previa: prenatal diagnosis, natural evolution, and clinical outcome. Obstet Gynecol 2000;95(4):572-6.
41. Hata K, Hata T, Fujiwaki R, et al. An accurate diagnosis of vasa previa with transvaginal color Doppler ultrasonography. Am J Obstet Gynecol 1994;171:265.
42. Ventura SJ, Martin JA, Curtin SC, et al. Final data for 1998. Natl Vital Stat Rep 2000;48(3):1-100.
43. Berg CJ, Atrash HK, Koonin LM, et al. Pregnancy-related mortality in the United States, 1987-1990. Obstet Gynecol 1996;88:161.
44. Naye RL, Friedman EA. Causes of perinatal death associated with gestational hypertension and proteinuria. Am J Obstet Gynecol 1979;133:8.
45. Sibai BM. Eclampsia: maternal-perinatal death outcome in 254 consecutive cases. Am J Obstet Gynecol 1990;163:1048.
46. National High Blood Pressure Education Program. Working group report on high blood pressure in pregnancy. Am J Obstet Gynecol 2000;183:51.
47. Cunningham FG, Gant NF, Leveno KJ, et al. Williams's obstetrics. 21st edition. New York: McGraw-Hill; 2001. p. 571-82, 591, 598-600, 604.
48. Palmer SK, Moore LG, Young DA, et al. Altered blood pressure and increased preeclampsia at high altitude (3200 meters) in Colorado. Am J Obstet Gynecol 1999;180:1161.
49. Ray JG, Burrows RF, Burrows EA, et al. MOS HIP: McMaster outcome study of hypertension in pregnancy. Early Hum Dev 2001;64(2):129-43,
50. Pearlman MD, Tintinalli JE. Emergency care of the woman. New York: McGraw-Hill; 1998. p. 59.
51. Marx JA, Hockberger RS, Waus RM, et al. Rosen's emergency medicine concepts and clinical practice. 5th edition. St. Louis (MO): Mosby; 2002. p. 2422-3.
52. Duley L, Henderson-Smart D. Magnesium sulphate versus diazepam for eclampsia. Cochrane Database Syst Rev 2000. 01 Jan 2000;(2):CD 000127.
53. Frakes MA, Richardson LE. Magnesium sulfate therapy in certain emergency conditions. Am J Emerg Med 1997;15(2):182-7.
54. Lucas MJ, Leveno KJ, Cunningham FG. A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. N Engl J Med 1995;333(4):201-5.
55. Witlin AG, Sibai BM. Magnesium sulfate therapy in preeclampsia and eclampsia. Obstet Gynecol 1998;92(5):883-9.
56. Vigil-De Gracia P. Pregnancy complicated by pre-eclampsia-eclampsia with HELLP syndrome. Int J Gynaecol Obstet 2001;72(1):17-23.